We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Revolutionary Genomic Handheld Device Offers First-of-Kind Point-of-Decision, Lab in Cartridge PCR Test

By LabMedica International staff writers
Posted on 08 Nov 2023
Print article
Image: The Lab-in-Cartridge system operates by placing a sample swab into a disposable cartridge that extracts RNA (Photo courtesy of Imperial College London)
Image: The Lab-in-Cartridge system operates by placing a sample swab into a disposable cartridge that extracts RNA (Photo courtesy of Imperial College London)

The world’s first handheld polymerase chain reaction (PCR) genomic diagnostic cartridge and chip offers the potential to transform the diagnosis of infections and cancer risk based on personal genomics at the point of decision.

DnaNudge (London, UK) and NantNudge (Los Angeles, CA, USA) have entered into a multi-million-dollar agreement wherein NantNudge will drive the worldwide adoption of rapid, lab-free point-of-decision diagnostics, targeting regions including the Americas and Africa. The collaboration aims to fulfill the urgent global demand for fast, cost-effective, and user-friendly multiplex RT-PCR testing that works even outside traditional clinical settings. DnaNudge’s Lab-in-Cartridge system simplifies the testing process: a user inserts a swab with a sample into a single-use cartridge that isolates RNA. This cartridge is then analyzed by the NudgeBox, which performs reverse transcription to DNA and delivers results in just over an hour.

Originally designed to combat lifestyle diseases like obesity and Type 2 diabetes, this innovative DNA testing approach has been quickly adapted in response to the COVID-19 pandemic by developing a rapid, lab-free CovidNudge RT-PCR test. The test can identify COVID-19 among other viruses within the same one-hour timeframe and is currently employed in healthcare facilities worldwide. NantNudge will produce the compact, RT-PCR NantCartridge, the NantBeam wearable device, and the NantChip cartridge, which brings the lab to the patient, for medical and consumer health applications. The NantBeam connects to smartphones, offering AI-driven advice on food and product choices based on a person’s unique genomic data.

NantNudge will be focusing on gaining regulatory approvals for the NantCartridge to be used in identifying a range of infectious diseases like COVID-19, influenza, RSV, TB, and bacterial infections, as well as evaluating cancer risks, all through analysis of a person's genomic blueprint at the point of care. NantNudge’s new “Quad” test is set to be released after it clears regulatory review, which will enable the detection of SARS-CoV-2, FluA, FluB, and RSV from just one sample. In addition, there are plans to begin co-developing comprehensive testing kits that work outside the lab, to tackle pressing global health issues including infectious diseases, personalized medicine, cancer, diabetes-related infections, STDs, and antibiotic resistance.

"This is a momentous day, both in terms of DnaNudge's commercial journey and for realizing our ambition of transforming global access to life-changing – and life-saving – near-patient diagnostics,” said Professor Chris Toumazou, Chairman and co-founder of DnaNudge.

"This genomics PCR device, I believe, will be an inflection point for capturing genomic signals on a very personalized basis and transforming how we work, live, and play,” added Dr. Patrick Soon-Shiong, founder of NantWorks and NantNudge.

Related Links:
DnaNudge 
NantNudge 

Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Liquid Based Cytology Production Machine
LBP-4032
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: Rapid and non-invasive analysis of paracetamol overdose using paper arrow-mass spectrometry (Photo courtesy of Dr Simon Maher/University of Liverpool)

New Saliva Test Rapidly Identifies Paracetamol Overdose

Paracetamol is the most widely used medication worldwide, and its easy availability contributes to its frequent misuse and overdose. Overdosing on paracetamol can lead to liver toxicity, requiring hospitalization.... Read more

Hematology

view channel
Image: RHD screening just got easier with single exon NIPT testing (Photo courtesy of Devyser)

Non-Invasive Test Solution Determines Fetal RhD Status from Maternal Plasma

RhD (rhesus D) is a blood group type that can trigger immune responses. Individuals who lack RhD on their red blood cells are classified as RhD-negative. These individuals may produce antibodies against... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: A new test finds bacteria in liquids and indicate their presence by changing color (Photo courtesy of Georgia Kirkos/McMaster University)

New Hands-Free Rapid Test Detects Bacteria in Fluids

Bacteriophages, the most abundant form of life on Earth, are specialized to target and destroy specific types of bacteria. Their natural ability to fight bacteria has long been harnessed to treat infections.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.